Coloplast — Management Reports 2015

Jun 16, 2015

Announcement No. 6/2015 16 June 2015

Financial guidance for 2014/15

Coloplast lowers guidance for 2014/15:

• As a result of continued challenges in our UK homecare business, Charter, as well as lower campaign activity in the US chronic care business, revenue expectations for the full-year are revised from an organic revenue growth of 8- 9% to an organic revenue growth of around 7%. In DKK this equals a revision from 13-14% to around 12%.
• The expected EBIT margin for 2014/15 is lowered from around 34% at constant exchange rates and in DKK to around 32%, both at constant exchange rates and in DKK. The EBIT margin is lowered partly due to expected lower sales. Furthermore, Coloplast has taken a provision in relation to the ongoing Department of Justice investigation in the US and increased the provision for bad debt in Southern Europe. Finally, Coloplast has taken a write-down on the NPWT inventory purchased from Devon Medical.
• Guidance for capital expenditure remains unchanged at around DKK 650m, and the effective tax rate is still expected to be about 24%.

Coloplast's long-term financial guidance remains to generate 7-10% sales growth per year and to improve the profit margin by 0.5-1.0 percentage point per year.

Coloplast's Interim Financial Report for Q3 2014/15 will be released on 11 August 2015.

Lars Rasmussen President & CEO

Conference call

Conference Call

Coloplast will hold a conference call today, 16 June 2015 at 12.00 CET. The call is expected to last 30 minutes. To attend the conference call, call +45 3271 4607, +44 (0)20 7162 0077 or +1 334 323 6201. Conference call reference no. 953886. A webcast will be posted on www.coloplast.com shortly after the conclusion of the conference call.

For further information, please contact

Investors and analysts

Ian S.E. Christensen Vice President, Investor Relations Tel. +45 4911 1800/+45 4911 1301 Email: dkisec@coloplast.com

Ellen Bjurgert Investor Relations Manager Tel. +45 4911 1800 / +45 4911 3376 E-mail: dkebj@coloplast.com

Press and the media

Simon Mehl Augustesen Media Relations Manager Tlf. 4911 3488 Email: dksia@coloplast.com

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 9,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2015-06 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.